載入...
Recombinant human erythropoietin does not affect several microvascular parameters in well‐trained cyclists
Recombinant human erythropoietin (rHuEPO) has been used as a performance‐enhancing agent by athletes in a variety of sports. The resulting increase in hematocrit levels leads to increased blood viscosity and can affect blood flow, potentially increasing the athlete's risk of developing health c...
Na minha lista:
| 發表在: | Physiol Rep |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6308108/ https://ncbi.nlm.nih.gov/pubmed/30592183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14814/phy2.13924 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|